Concepedia

Ana M. Metelo

AM

Statistics

Publications

6

Citations

509

H-Index

6

Active since

2010

Affiliations

University of Coimbra(Current)

Center for Cancer Research

Massachusetts General Hospital

Instituto de Investigaciones Biomédicas Sols-Morreale

Broad Institute

Ana M. Metelo is an author at University of Coimbra specializing in medicine, vhl gene alterations, and diabetes mellitus.

ORCID

Publications per year

2010–2022

6

Publications

6

In Vivo HIF-Mediated Reductive Carboxylation Is Regulated by Citrate Levels and Sensitizes VHL-Deficient Cells to Glutamine Deprivation

Paulo A. Gameiro, Juanjuan Yang, Ana M. Metelo et al. · Cell Metabolism · 2013 · 329 citations · Full text

, , +13

Pharmacological HIF2α inhibition improves VHL disease–associated phenotypes in zebrafish model

Ana M. Metelo, Haley R. Noonan, Xiang Li et al. · Journal of Clinical Investigation · 2015 · 50 citations · Full text

, , +13

Allogeneic Anti-BCMA CAR T Cells Are Superior to Multiple Myeloma-derived CAR T Cells in Preclinical Studies and May Be Combined with Gamma Secretase Inhibitors

Ana M. Metelo, Agnieszka Jóźwik, Le Anh Luong et al. · Cancer Research Communications · 2022 · 39 citations · Full text

, , +17

Study of the antidiabetic capacity of the VO(dmpp)2 complex

Marta Passadouro, Ana M. Metelo, Alice Melão et al. · Journal of Inorganic Biochemistry · 2010 · 34 citations

, , +11

VO(dmpp)2 normalizes pre-diabetic parameters as assessed by in vivo magnetic resonance imaging and spectroscopy

Ana M. Metelo, Rocío Pérez-Carro, M. Margarida C. A. Castro et al. · Journal of Inorganic Biochemistry · 2012 · 29 citations · Full text

, , +7

1–5 of 6